Recruiting
Empowerment and Mobile Technology in the Control of Cardiovascular Risk Factors in Patients With Ischemic Stroke
The CARDIOSTROKE is a randomized trial comparing mobile-device assisted control of hypertension together with screening of occult atrial fibrillation to standard care in patients with recent ischemic stroke or transient ischemic attack.
ClinicalTrials.gov IDNCT03710902
PhaseNA
Enrollment405
SponsorJukka Putaala
Age40 Years
SexALL
Conditions studied
Ischemic Stroke, Transient Ischemic Attack, Atrial Fibrillation, Hypertension, Empowerment
About this study
The CARDIOSTROKE is a randomized trial comparing mobile-device assisted control of hypertension together with screening of occult atrial fibrillation to standard care in patients with recent ischemic stroke or transient ischemic attack.
Interventions
- Diagnostic Test: ECG monitoring for 3 weeks — A 3-week continuous ECG monitoring to detect occult AF.
- Other: Self-monitoring of BP and self-titration of antihypertensive medication — One-week monthly self-monitoring of BP and self-titration of antihypertensive medication according to a pre-specified protocol, assisted with a mobile device application.
Primary outcomes
- Number of Participants with New Atrial fibrillation (12 months)
- Change in Blood Pressure (12 months)
Eligibility information
Inclusion Criteria:
* Ischemic stroke or transient ischemic attack (ABCD2 score ≥3)
* Age ≥40 years
* Pre-existing or newly diagnosed hypertension
* Informed consent from the patient or legal representative
Exclusion Criteria:
* Known high-risk source of cardioembolism
* Known indication for anticoagulation
* Contraindication for anticoagulation
* Pacemaker
* Non-compliance to study interventions as judged by the investigator
* Serious condition hampering the study conduct
Study locations
- Kanta-Häme Central Hospital, Hämeenlinna, Finland
- Helsinki University Hospital, Helsinki, 00290 Finland
- Hyvinkää Hospital, Hyvinkää, Finland
- Päijät-Häme Central Hospital, Lahti, Finland
Before you participate: Varda Clinical is an independent discovery tool, not the study sponsor or a medical provider. Eligibility can only be determined by the official study team. Discuss potential risks and benefits with a qualified healthcare professional.
Source: ClinicalTrials.gov. Record last refreshed by Varda Clinical: 2026-09-27.